Jul. 28, 2010 (Business Wire) -- Stericycle, Inc. (NASDAQ:SRCL), today reported financial results for the second quarter of 2010.
Revenues for the quarter ended June 30, 2010 were $347.7 million, up 20.2% from $289.3 million from the same quarter last year. Acquisitions less than 12 months old contributed approximately $29.2 million to the growth in revenues. Impact from foreign exchange in the quarter was immaterial. Gross profit was $161.5 million, up 18.3% from $136.5 million in the second quarter last year. Gross profit as a percent of revenue was 46.5% compared with 47.2% in the second quarter of 2009. Gross profit for the second quarter of 2010 was unfavorably impacted by $0.7 million of restructuring costs for our regulated returns management services business, or 0.2% of revenue.
Net income attributable to Stericycle for the second quarter of 2010 was $53.1 million or $0.61 per diluted share compared with $43.9 million or $0.51 per diluted share for the second quarter of 2009, up 21.1%. Net income attributable to Stericycle for the second quarter of 2010 reflected various non-operational items, which taken together, resulted in non-GAAP earnings per diluted share of $0.62 (see table below). Our non-GAAP earnings per diluted share increased 18.6% from our non-GAAP earnings per share of $0.52 in the second quarter of 2009.
FIRST SIX MONTHS’ RESULTS
For the six months ending June 30, 2010, revenues were $682.9 million, up 20.6% from $566.4 million in the same period last year. Revenues increased 19.7% compared with the prior period when adjusted for favorable foreign exchange impacts of $5.1 million. Gross profit was $316.9 million, up 19.9% from $264.3 million in the same period last year. Gross profit as a percent of revenue was 46.4% compared with 46.7% in 2009. Earnings per diluted share increased 20.0% to $1.17 from $0.97 per diluted share in the same period last year. Non-GAAP earnings per diluted share, when adjusted for various non-operational items, increased from $0.99 to $1.18, or 19.3% (see table below):
| Table to reconcile non-GAAP EPS to GAAP EPS | ||||||||||||||||
| Three months ended June 30, | Six months ended June 30, | |||||||||||||||
| 2010 | 2009 | Change | Change | 2010 | 2009 | Change | Change | |||||||||
| GAAP EPS | $0.61 | $0.51 | $0.11 | 21.1% | $1.17 | $0.97 | $0.19 | 20.0% | ||||||||
| Transactional expenses | ||||||||||||||||
| related to acquisitions | 0.01 | 0.01 | 0.01 | 0.02 | ||||||||||||
| Restructuring Costs/Plant | ||||||||||||||||
| Closure Expense | 0.01 | - | 0.02 | - | ||||||||||||
| Litigation Settlement | 0.01 | - | 0.01 | - | ||||||||||||
| Gain on Sale of Assets | (0.02) | - | (0.02) | - | ||||||||||||
| Non-GAAP EPS (adjusted) | $0.62 | $0.52 | $0.10 | 18.6% | $1.18 | $0.99 | $0.19 | 19.3% | ||||||||
* In accordance with U.S. generally accepted accounting principles (GAAP), reported earnings per share include the after-tax impact of the items identified in this table. For internal purposes, including the determination of management compensation, the Company excludes these items from results when evaluating operating performance. This table and the Company’s internal use of non-GAAP earnings per share are not intended to imply, and should not be interpreted as implying, that non-GAAP earnings per share is a better measure of performance than GAAP earnings per share.
Cash flow from operations was $129.3 million for the six months ended June 30, 2010.
For more information about Stericycle, please visit our website at www.stericycle.com.
Conference call to be held July 28, 2010 at 4:00 p.m. Central time – Dial 866-516-6872 at least 5 minutes before start time. If you are unable to participate on the call, a replay will be available through August 28th by dialing 800-642-1687, access code 84295630. To hear a live simulcast of the call over the internet on www.earnings.com, or to access an audio archive of the call, go to the Investors page on Stericycle’s website at www.stericycle.com.
Safe Harbor Statement: Statements in this press release may contain forward-looking statements that involve risks and uncertainties, some of which are beyond our control (for example, general economic conditions). Our actual results could differ significantly from the results described in the forward-looking statements. Factors that could cause such differences include changes in governmental regulation of medical waste collection and treatment and increases in transportation and other operating costs, as well as the other factors described in our filings with the U.S. Securities and Exchange Commission. As a result, past financial performance should not be considered a reliable indicator of future performance, and investors should not use historical trends to anticipate future results or trends. We make no commitment to disclose any subsequent revisions to forward-looking statements.
| STERICYCLE, INC. AND SUBSIDIARIES | |||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | |||||
| (IN THOUSANDS EXCEPT FOR SHARE AND PER SHARE DATA) | |||||
| June 30, | December 31, | ||||
| 2010 | 2009 | ||||
| (unaudited) | (audited) | ||||
| ASSETS | |||||
| Current Assets: | |||||
| Cash and cash equivalents | $ | 8,251 | $ | 15,767 | |
| Short-term investments | 2,234 | 1,131 | |||
| Accounts receivable, less allowance for doubtful | |||||
| accounts of $9,592 in 2010 and $8,709 in 2009 | 194,306 | 179,770 | |||
| Deferred income taxes | 16,458 | 14,087 | |||
| Prepaid expenses | 13,836 | 12,421 | |||
| Other current assets | 25,975 | 23,364 | |||
| Total Current Assets | 261,060 | 246,540 | |||
| Property, plant and equipment, net | 252,391 | 246,154 | |||
| Other assets: | |||||
| Goodwill | 1,452,051 | 1,394,091 | |||
| Intangible assets, less accumulated amortization of | |||||
| $22,322 in 2010 and $18,546 in 2009 | 309,562 | 269,454 | |||
| Other | 25,924 | 26,564 | |||
| Total Other Assets | 1,787,537 | 1,690,109 | |||
| Total Assets | $ | 2,300,988 | $ | 2,182,803 | |
| LIABILITIES AND SHAREHOLDERS' EQUITY | |||||
| Current Liabilities: | |||||
| Current portion of long-term debt | $ | 92,490 | $ | 78,026 | |
| Accounts payable | 44,051 | 47,608 | |||
| Accrued liabilities | 99,209 | 92,226 | |||
| Deferred revenues | 16,568 | 14,954 | |||
| Total Current Liabilities | 252,318 | 232,814 | |||
| Long-term debt, net of current portion | 859,429 | 910,825 | |||
| Deferred income taxes | 196,061 | 171,744 | |||
| Other liabilities | 13,777 | 10,247 | |||
| Shareholders' Equity: | |||||
| Common stock | |||||
| (par value $0.01 per share, 120,000,000 shares authorized, | |||||
| 85,380,255 issued and outstanding in 2010 and 84,715,005 | |||||
| issued and outstanding in 2009) | 854 | 847 | |||
| Additional paid-in capital | 69,410 | 47,522 | |||
| Accumulated other comprehensive loss | (31,892) | (12,292) | |||
| Retained earnings | 910,831 | 809,618 | |||
| Total Stericycle, Inc. Shareholders' Equity | 949,203 | 845,695 | |||
| Noncontrolling interests | 30,200 | 11,478 | |||
| Total Shareholders' Equity | 979,403 | 857,173 | |||
| Total Liabilities and Shareholders' Equity | $ | 2,300,988 | $ | 2,182,803 | |
| STERICYCLE, INC. AND SUBSIDIARIES | |||||||||||||||||||||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||||||||||||||||||||||
| (IN THOUSANDS EXCEPT FOR SHARE AND PER SHARE DATA) | |||||||||||||||||||||||||||||
| Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||
| June 30, | June 30, | ||||||||||||||||||||||||||||
| 2010 | 2009 | 2010 | 2009 | ||||||||||||||||||||||||||
| (unaudited) | (unaudited) | ||||||||||||||||||||||||||||
| $ | % of Rev | $ | % of Rev | $ | % of Rev | $ | % of Rev | ||||||||||||||||||||||
| Revenues | $ | 347,734 | 100.0 | % | $ | 289,268 | 100.0 | % | $ | 682,911 | 100.0 | % | $ | 566,358 | 100.0 | % | |||||||||||||
| Cost of revenues | 185,471 | 53.3 | % | 152,734 | 52.8 | % | 364,903 | 53.4 | % | 302,021 | 53.3 | % | |||||||||||||||||
| Restructuring Costs | 726 | 0.2 | % | - | 0.0 | % | 1,154 | 0.2 | % | - | 0.0 | % | |||||||||||||||||
| Gross profit | 161,537 | 46.5 | % | 136,534 | 47.2 | % | 316,854 | 46.4 | % | 264,337 | 46.7 | % | |||||||||||||||||
| Selling, general and administrative expenses | 65,091 | 18.7 | % | 54,215 | 18.7 | % | 129,113 | 18.9 | % | 106,087 | 18.7 | % | |||||||||||||||||
| Amortization | 2,159 | 0.6 | % | 1,376 | 0.5 | % | 4,134 | 0.6 | % | 2,386 | 0.4 | % | |||||||||||||||||
| Total SG&A expense and amortization | 67,250 | 19.3 | % | 55,591 | 19.2 | % | 133,247 | 19.5 | % | 108,473 | 19.2 | % | |||||||||||||||||
| Income from operations before | |||||||||||||||||||||||||||||
| acquisition, integration, and other expenses | 94,287 | 27.1 | % | 80,943 | 28.0 | % | 183,607 | 26.9 | % | 155,864 | 27.5 | % | |||||||||||||||||
| Transactional expenses related to acquisitions | 556 | 0.2 | % | 1,330 | 0.5 | % | 1,356 | 0.2 | % | 1,940 | 0.3 | % | |||||||||||||||||
| Restructuring costs and | |||||||||||||||||||||||||||||
| plant closure expense | 837 | 0.2 | % | - | 0.0 | % | 1,076 | 0.2 | % | - | 0.0 | % | |||||||||||||||||
| Litigation settlement | 937 | 0.3 | % | - | 0.0 | % | 937 | 0.1 | % | - | 0.0 | % | |||||||||||||||||
| Gain on sale of assets | (2,955 | ) | -0.8 | % | - | 0.0 | % | (2,955 | ) | -0.4 | % | - | 0.0 | % | |||||||||||||||
| Acquisition integration expenses | 1,314 | 0.4 | % | 73 | 0.0 | % | 2,463 | 0.4 | % | 184 | 0.0 | % | |||||||||||||||||
| Income from operations | 93,598 | 26.9 | % | 79,540 | 27.5 | % | 180,730 | 26.5 | % | 153,740 | 27.1 | % | |||||||||||||||||
| Other income (expense): | |||||||||||||||||||||||||||||
| Interest income | 32 | 0.0 | % | 49 | 0.0 | % | 112 | 0.0 | % | 223 | 0.0 | % | |||||||||||||||||
| Interest expense | (8,870 | ) | -2.6 | % | (8,200 | ) | -2.8 | % | (17,833 | ) | -2.6 | % | (16,299 | ) | -2.9 | % | |||||||||||||
| Other expense, net | (892 | ) | -0.3 | % | (828 | ) | -0.3 | % | (1,895 | ) | -0.3 | % | (1,618 | ) | -0.3 | % | |||||||||||||
| Total other income (expense) | (9,730 | ) | -2.8 | % | (8,979 | ) | -3.1 | % | (19,616 | ) | -2.9 | % | (17,694 | ) | -3.1 | % | |||||||||||||
| Income before income taxes | 83,868 | 24.1 | % | 70,561 | 24.4 | % | 161,114 | 23.6 | % | 136,046 | 24.0 | % | |||||||||||||||||
| Income tax expense | 30,102 | 8.7 | % | 26,567 | 9.2 | % | 58,714 | 8.6 | % | 51,378 | 9.1 | % | |||||||||||||||||
| Net income | 53,766 | 15.5 | % | 43,994 | 15.2 | % | 102,400 | 15.0 | % | 84,668 | 14.9 | % | |||||||||||||||||
| Net income attributable to | |||||||||||||||||||||||||||||
| noncontrolling interests | 672 | 0.2 | % | 92 | 0.0 | % | 1,187 | 0.2 | % | 111 | 0.0 | % | |||||||||||||||||
| Net income attributable to Stericycle, Inc. | $ | 53,094 | 15.3 | % | $ | 43,902 | 15.2 | % | $ | 101,213 | 14.8 | % | $ | 84,557 | 14.9 | % | |||||||||||||
| Earnings per share-diluted | $ | 0.61 | $ | 0.51 | $ | 1.17 | $ | 0.97 | |||||||||||||||||||||
| Weighted average number of | |||||||||||||||||||||||||||||
| common shares outstanding-diluted | 86,694,239 | 86,843,260 | 86,646,109 | 86,843,043 | |||||||||||||||||||||||||
| STERICYCLE, INC. AND SUBSIDIARIES | ||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
| (IN THOUSANDS) | ||||||||
| For the six months ended | ||||||||
| June 30, | ||||||||
| 2010 | 2009 | |||||||
| (unaudited) | (unaudited) | |||||||
| Operating Activities: | ||||||||
| Net income | $ | 102,400 | $ | 84,668 | ||||
| Adjustments to reconcile net income to net cash | ||||||||
| provided by operating activities: | ||||||||
| Gain on sale of assets | (2,955 | ) | - | |||||
| Plant closure expense | 478 | - | ||||||
| Stock compensation expense | 7,741 | 7,092 | ||||||
| Excess tax benefit of stock options exercised | (13,430 | ) | (551 | ) | ||||
| Depreciation | 20,872 | 16,118 | ||||||
| Amortization | 4,134 | 2,386 | ||||||
| Deferred income taxes | 12,110 | 11,976 | ||||||
| Changes in operating assets and liabilities, net of | ||||||||
| effect of acquisitions and divestitures: | ||||||||
| Accounts receivable | (11,688 | ) | 12,302 | |||||
| Accounts payable | (5,436 | ) | (7,806 | ) | ||||
| Accrued liabilities | 9,042 | (1,620 | ) | |||||
| Deferred revenue | 1,826 | 181 | ||||||
| Other assets | 4,211 | 1,456 | ||||||
| Net cash provided by operating activities | 129,305 | 126,202 | ||||||
| Investing Activities: | ||||||||
| Payments for acquisitions and international | ||||||||
| investments, net of cash acquired | (67,826 | ) | (60,519 | ) | ||||
| Proceeds from / (purchases of) short-term investments | (911 | ) | 513 | |||||
| Proceeds from sale of assets | 8,000 | 448 | ||||||
| Capital expenditures | (25,017 | ) | (17,904 | ) | ||||
| Net cash used by investing activities | (85,754 | ) | (77,462 | ) | ||||
| Financing Activities: | ||||||||
| Repayment of long-term debt | (44,126 | ) | (11,383 | ) | ||||
| Net payments on senior credit facility | (18,249 | ) | (71,762 | ) | ||||
| Proceeds from term loan | - | 50,000 | ||||||
| Payments of deferred financing costs | - | (888 | ) | |||||
| Payments on capital lease obligations | (1,829 | ) | (122 | ) | ||||
| Purchase/ cancellation of treasury stock | (24,260 | ) | (29,975 | ) | ||||
| Proceeds from other issuances of common stock | 25,334 | 9,163 | ||||||
| Excess tax benefit of stock options exercised | 13,430 | 551 | ||||||
| Net cash used by financing activities | (49,700 | ) | (54,416 | ) | ||||
| Effect of exchange rate changes on cash | (1,367 | ) | (737 | ) | ||||
| Net decrease in cash and cash equivalents | (7,516 | ) | (6,413 | ) | ||||
| Cash and cash equivalents at beginning of period | 15,767 | 9,095 | ||||||
| Cash and cash equivalents at end of period | $ | 8,251 | $ | 2,682 | ||||
| Non-cash activities: | ||||||||
| Net issuances of notes payable for certain acquisitions | $ | 31,042 | $ | 20,756 | ||||
